Ayolola Eni‐Olotu
Biographic Data
| ID | 7990246 |
|---|---|
| NAME | Ayolola Eni‐Olotu |
| GIVEN NAMES | Ayolola |
| FAMILY NAME | Eni‐Olotu |
| SIGNATURE | OLOTU A E |
| AFFILIATIONS | Imperial College London |
| ORCID | 0000-0002-9187-9692 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Achieving equitable access to health technologies during a pandemic
The COVID-19 pandemic underlined stark inequalities in timely access to health technologies worldwide. Universities, by conducting a significant amount of early biomedical research and development, have a critical but often overlooked role in determining downstream equitable access to health technologies. This paper reviews university's policies and practices regarding COVID-19 health technologies in the United Kingdom (UK) during the recent pand…
Who funded the research behind the Oxford–AstraZeneca Covid-19 vaccine
OBJECTIVES: The Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19, Vaxzevira or Covishield) builds on two decades of research and development (R&D) into chimpanzee adenovirus-vectored vaccine (ChAdOx) technology at the University of Oxford. This study aimed to approximate the funding for the R&D of ChAdOx and the Oxford-AstraZeneca vaccine and to assess the transparency of funding reporting mechanisms. METHODS: We conducted a scoping review an…
No prominent works on this page.
Who funded the research behind the Oxford–AstraZeneca Covid-19 vaccine
OBJECTIVES: The Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1 nCoV-19, Vaxzevira or Covishield) builds on two decades of research and development (R&D) into chimpanzee adenovirus-vectored vaccine (ChAdOx) technology at the University of Oxford. This study aimed to approximate the funding for the R&D of ChAdOx and the Oxford-AstraZeneca vaccine and to assess the transparency of funding reporting mechanisms. METHODS: We conducted a scoping review an…
Achieving equitable access to health technologies during a pandemic
The COVID-19 pandemic underlined stark inequalities in timely access to health technologies worldwide. Universities, by conducting a significant amount of early biomedical research and development, have a critical but often overlooked role in determining downstream equitable access to health technologies. This paper reviews university's policies and practices regarding COVID-19 health technologies in the United Kingdom (UK) during the recent pand…
Medicine (2 works) · Political science (2 works) · 2019-20 coronavirus outbreak (1 work) · Biomedical Ethics and Regulation (1 work) · Business (1 work) · Coronavirus disease 2019 (COVID-19 (1 work) · Disease (1 work) · Economic growth (1 work) · Economics (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work)